Companies: 11,342     total market cap: โ‚ฌ136.237 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Ascendis Pharma
ASND
#1439
Rank
โ‚ฌ13.37 B
Marketcap
๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Country
203,28ย โ‚ฌ
Share price
0.25%
Change (1 day)
12.93%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): 11,87ย โ‚ฌ

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is 12,19ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,82ย โ‚ฌ an increase over its 2024 EPS that were of -6,35ย โ‚ฌ.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)11,87ย โ‚ฌ-410.63%
2025-3,82ย โ‚ฌ-39.79%
2024-6,35ย โ‚ฌ-23.17%
2023-8,26ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
-0,09813ย โ‚ฌ-100.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-4,66ย โ‚ฌ-138.26%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-8,64ย โ‚ฌ-170.93%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com